| 278 |
3,3
|
|
None
|
| 277 |
3,3'
|
|
None
|
| 835 |
3,3',5,5'-Tetrabromobisphenol A
|
-
3,3',5,5'-Tetrabromobisphenol A, CAS-RN: 79-94-7, DTXSID1026081
|
565: 17β-Hydroxysteroid dehydrogenase 2, inhibition leading to activation, estrogen receptor alpha
|
| 758 |
3,3′,5,5′ tetrabromobisphenol A
|
|
2 AOPs
|
| 321 |
3,5-Dichlorophenol
|
-
3,5-Dichlorophenol, CAS-RN: 591-35-5, DTXSID2025006
|
2 AOPs
|
| 466 |
4-biphenyl carboxylic acid
|
|
297: Inhibition of retinaldehyde dehydrogenase leads to population decline
|
| 832 |
4-bromo-2-(methylamino)-benzimidazole
|
|
562: HCN Channel Inhibition leading to Arrhythmias
|
| 728 |
4-diethylaminobenzaldehyde (DEAB)
|
|
436: Inhibition of RALDH2 causes reduced all-trans retinoic acid levels, leading to transposition of the great arteries
|
| 363 |
4-Hydroxy Nonenal
|
|
None
|
| 583 |
4-Hydroxytamoxifen
|
-
4-Hydroxytamoxifen, CAS-RN: 68392-35-8, DTXSID3037094
|
None
|
| 515 |
4-Nitroquinoline 1-oxide
|
|
296: Oxidative DNA damage leading to chromosomal aberrations and mutations
|
| 77 |
4-Nonylphenol
|
-
4-Nonylphenol, CAS-RN: 104-40-5, DTXSID5033836
|
None
|
| 78 |
4-propoxyphenol
|
|
None
|
| 220 |
5-(N,N-hexamethylene) amiloride (HMA)
|
|
None
|
| 442 |
5-Azacytidine
|
-
5-Azacytidine, CAS-RN: 320-67-2, DTXSID9020116
|
8 AOPs
|
| 126 |
518-2-5
|
|
None
|
| 267 |
5alpha-Dihydrotestosterone
|
-
5alpha-Dihydrotestosterone, CAS-RN: 521-18-6, DTXSID9022364
|
376: Androgen receptor agonism leading to male-biased sex ratio
|
| 836 |
7,12-Dimethylbenz(a)anthracene
|
-
7,12-Dimethylbenz(a)anthracene, CAS-RN: 57-97-6, DTXSID1020510
|
563: Aryl hydrocarbon Receptor (AHR) activation causes Premature Ovarian Insufficiency via Bax mediated apoptosis
|
| 730 |
a
|
|
None
|
| 544 |
Abamectin
|
-
Abamectin, CAS-RN: 71751-41-2, DTXSID8023892
|
None
|
| 656 |
Acetaldehyde
|
-
Acetaldehyde, CAS-RN: 75-07-0, DTXSID5039224
|
None
|
| 57 |
Acetaminophen
|
-
Acetamide, CAS-RN: 60-35-5, DTXSID7020005
-
Acetaminophen, CAS-RN: 103-90-2, DTXSID2020006
-
Acetohexamide, CAS-RN: 968-81-0, DTXSID7020007
|
260: CYP2E1 activation and formation of protein adducts leading to neurodegeneration
|
| 553 |
acetone
|
-
Acetone, CAS-RN: 67-64-1, DTXSID8021482
|
None
|
| 366 |
Acetyldehyde
|
|
None
|
| 8 |
Aceytlsalicylic acid
|
-
Aspirin, CAS-RN: 50-78-2, DTXSID5020108
|
None
|